Lack of neurofibromin results in increased RAS signaling and the development of NF-1-associated neoplasms such as peripheral nerve sheath tumors, pheochromocytoma, myeloid dysplasia and neurofibromas [17,18]. Here, NF1 is linked to neoplasm.